by 
The DNA synthesizer market has experienced significant growth owing to increased research and development activities in the field of synthetic biology and genomics. DNA synthesizers have made DNA synthesis automated, affordable and accessible and enable rapid production of oligonucleotides which are widely used for genetic engineering, diagnostic development and forensic analysis. The Global DNA Synthesizer Market is estimated to be valued at US$ 4.3 Bn in 2024 and is expected to exhibit a CAGR of 20% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the DNA synthesizer market are Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation (Integrated DNA Technologies), GenScript Biotech Corporation, Eurofins Genomics, LGC Limited, BioAutomation Corporation, Bio-Rad Laboratories, Twist Bioscience Corporation, Hamilton Company, New England Biolabs, Nippon Genetics, LGC Biosearch Technologies, DNA Script, Ribbon Biolabs GmbH, and Camena Bioscience. Key players like Thermo Fisher Scientific, Merck KGaA and Agilent Technologies dominate the market with their wide range of DNA synthesizer products.
The growing demand for DNA in research activities related to genomics, biotechnology and pharmaceutical industry has fueled the growth of the DNA synthesizer market. Developing regions in Asia Pacific and Latin America are witnessing rising investments in genomics and biotechnology which is driving the demand for DNA synthesizers in these regions.
Global expansion across emerging markets in Asia and Latin America through collaborations with regional research institutes and setting up of manufacturing plants will help key players leverage opportunities in high growth regions. Increased accessibility of DNA synthesizers in these regions will support regional life sciences research.
Market Key Trends
The DNA synthesizer market is witnessing increased adoption of solid phase synthesis technology. Solid phase synthesis allows for production of longer oligonucleotides with reduced error rates compared to traditional phosphorylation based solution phase synthesis. Continuous innovation and technology advancements have led to development of DNA synthesizer products with faster synthesis cycles, improved throughput and reliability using solid phase synthesis. Automation of DNA synthesis workflow with integration of liquid handling robots further enhances productivity and efficiency of DNA synthesizers based on solid phase technology. This trend is expected to continue driving the DNA synthesizer market growth over the forecast period.
Porter’s Analysis
Threat of new entrants: The DNA Synthesizer market requires a significant amount of capital investments, technological advancements and R&D expenses putting barriers for new players to easily enter the market.
Bargaining power of buyers: Buyers have moderate bargaining power in this market as there are numerous established players providing DNA synthesizers with different designs and customization options.
Bargaining power of suppliers: Suppliers have low bargaining power due to availability of alternative components and parts suppliers in the market reducing dependence on few suppliers.
Threat of new substitutes: There are limited substitutes available for DNA synthesizers currently as it provides unique technologies for gene synthesis.
Competitive rivalry: The competitive rivalry in the market is high owing to presence of numerous global and local players offering differentiated value propositions.
Geographical Regions
North America is dominating the DNA Synthesizer market currently accounting for over 40% share in terms of value owing to presence of leading life science research organizations and companies.
Asia Pacific is expected to emerge as the fastest growing region during the forecast period supported by rising R&D investments, establishment of genomics clusters and expansion of healthcare infrastructure in countries like China and India.
